An Open-Access Dataset of Thorough QT Studies Results

Along with the current interest in changes of cardiovascular risk assessment strategy and inclusion of in silico modelling into the applicable paradigm, the need for data has increased, both for model generation and testing. Data collection is often time-consuming but an inevitable step in the model...

Full description

Bibliographic Details
Main Authors: Barbara Wiśniowska, Zofia Tylutki, Sebastian Polak
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Data
Subjects:
Online Access:https://www.mdpi.com/2306-5729/5/1/10
_version_ 1811303887341092864
author Barbara Wiśniowska
Zofia Tylutki
Sebastian Polak
author_facet Barbara Wiśniowska
Zofia Tylutki
Sebastian Polak
author_sort Barbara Wiśniowska
collection DOAJ
description Along with the current interest in changes of cardiovascular risk assessment strategy and inclusion of in silico modelling into the applicable paradigm, the need for data has increased, both for model generation and testing. Data collection is often time-consuming but an inevitable step in the modelling process, requiring extensive literature searches and other identification of alternative resources providing complementary results. The next step, namely data extraction, can also be challenging. Here we present a collection of thorough QT/QTc (TQT) study results with detailed descriptions of study design, pharmacokinetics, and pharmacodynamic endpoints. The presented dataset provides information that can be further utilized to assess the predictive performance of different preclinical biomarkers for QT prolongation effects with the use of various modelling approaches. As the exposure levels and population description are included, the study design and characteristics of the study population can be recovered precisely in the simulation. Another possible application of the TQT dataset is the analysis of drug characteristic/QT prolongation/TdP (torsade de pointes) relationship after the integration of provided information with other databases and tools. This includes drug cardiac safety classifications (e.g., CredibleMeds), Comprehensive in vitro Proarrhythmia Assay (CiPA) compounds classification, as well as those containing information on physico-chemical properties or absorption, distribution, metabolism, excretion (ADME) data like PubChem or DrugBank.
first_indexed 2024-04-13T07:56:15Z
format Article
id doaj.art-d519e4d7cbdf4919a97991a38a99e75c
institution Directory Open Access Journal
issn 2306-5729
language English
last_indexed 2024-04-13T07:56:15Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Data
spelling doaj.art-d519e4d7cbdf4919a97991a38a99e75c2022-12-22T02:55:24ZengMDPI AGData2306-57292020-01-01511010.3390/data5010010data5010010An Open-Access Dataset of Thorough QT Studies ResultsBarbara Wiśniowska0Zofia Tylutki1Sebastian Polak2Pharmacoepidemiology and Farmacoeconomics Unit, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, str., 30-688 Krakow, PolandPharmacoepidemiology and Farmacoeconomics Unit, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, str., 30-688 Krakow, PolandPharmacoepidemiology and Farmacoeconomics Unit, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, str., 30-688 Krakow, PolandAlong with the current interest in changes of cardiovascular risk assessment strategy and inclusion of in silico modelling into the applicable paradigm, the need for data has increased, both for model generation and testing. Data collection is often time-consuming but an inevitable step in the modelling process, requiring extensive literature searches and other identification of alternative resources providing complementary results. The next step, namely data extraction, can also be challenging. Here we present a collection of thorough QT/QTc (TQT) study results with detailed descriptions of study design, pharmacokinetics, and pharmacodynamic endpoints. The presented dataset provides information that can be further utilized to assess the predictive performance of different preclinical biomarkers for QT prolongation effects with the use of various modelling approaches. As the exposure levels and population description are included, the study design and characteristics of the study population can be recovered precisely in the simulation. Another possible application of the TQT dataset is the analysis of drug characteristic/QT prolongation/TdP (torsade de pointes) relationship after the integration of provided information with other databases and tools. This includes drug cardiac safety classifications (e.g., CredibleMeds), Comprehensive in vitro Proarrhythmia Assay (CiPA) compounds classification, as well as those containing information on physico-chemical properties or absorption, distribution, metabolism, excretion (ADME) data like PubChem or DrugBank.https://www.mdpi.com/2306-5729/5/1/10dataset: 10.17632/47nknnw666.1
spellingShingle Barbara Wiśniowska
Zofia Tylutki
Sebastian Polak
An Open-Access Dataset of Thorough QT Studies Results
Data
dataset: 10.17632/47nknnw666.1
title An Open-Access Dataset of Thorough QT Studies Results
title_full An Open-Access Dataset of Thorough QT Studies Results
title_fullStr An Open-Access Dataset of Thorough QT Studies Results
title_full_unstemmed An Open-Access Dataset of Thorough QT Studies Results
title_short An Open-Access Dataset of Thorough QT Studies Results
title_sort open access dataset of thorough qt studies results
topic dataset: 10.17632/47nknnw666.1
url https://www.mdpi.com/2306-5729/5/1/10
work_keys_str_mv AT barbarawisniowska anopenaccessdatasetofthoroughqtstudiesresults
AT zofiatylutki anopenaccessdatasetofthoroughqtstudiesresults
AT sebastianpolak anopenaccessdatasetofthoroughqtstudiesresults
AT barbarawisniowska openaccessdatasetofthoroughqtstudiesresults
AT zofiatylutki openaccessdatasetofthoroughqtstudiesresults
AT sebastianpolak openaccessdatasetofthoroughqtstudiesresults